BamSEC and AlphaSense Join Forces
Learn More

Denali Therapeutics Inc. – Indentures

NASDAQ: DNLI    
Share price (7/2/26): $25.83    
Market cap (7/2/26): $4.099 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 17 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.2
from S-3ASR 45 pages Denali Therapeutics Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-Q 13 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 12 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.4
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-3ASR 45 pages Denali Therapeutics Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.3
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.1
from S-1 157 pages Investors’ Rights Agreement
12/34/56
EX-4
from DRS 157 pages Investors’ Rights Agreement
12/34/56